Pain, headache, and migraine is the main area connected here, and any felt benefit should be read together with the human evidence base.
Some human supplement-context evidence is present and directly informs the score.
Representative tier calculated from paper evidence that passed the collection audit.
The representative ingredient tier is calculated from these target-level evidence groups.
Potential benefit studied in Pain and headache. These findings come from a defined study population, so everyday effects may differ.
This score reflects the strength of this benefit group. The ingredient tier also considers paper count, repetition, population, and study context.
Potential benefit studied in Skin, hair, and nails.
This score reflects the strength of this benefit group. The ingredient tier also considers paper count, repetition, population, and study context.
Findings from studies of this ingredient alone are separated from findings involving another supplement or medication.
No standalone side-effect or combination signal is currently clear enough to show from the collected papers. This does not mean there is no concern.
Paper IDs and full lists are private. Only study types and summaries are shown.
This review describes metabolisms, different physi - ological and pathological functions, basic pharmacological properties, and the clinical use of hyaluronic acid.
CD44 was revealed as a potential therapeutic target in systemic inflammatory responses involving the liver by a dramatic induction of serum-derived HA-associated protein in sinusoids in response to lipopolysaccharide (LPS).
This review discusses the genesis and consequences of altered fluid dynamics in PDA and strategies to restore them and focuses on altered physicomechanics as one mechanism of what is termed as ‘stromal resistance’ in Pda.
The biological effect of HA on the skin level and its potential adverse effects are discussed and some available cosmetic products containing HA have been identified from the brand portfolio of most known manufacturers and their composition was evaluated.
The results suggest that the GNR-HA-ALA/Cy7.5-HER2 could serve as a promising nanoplatform for HER2-positive breast cancer therapy, which is compromised by the nonspecific delivery and unintended release of photo-responsive agents.
The age-related increase in cartilage wear in non-osteoarthritic joints may be related to the altered hyaluronan content and quality of synovial fluid.